Sort
48,018 grants matching “immunotherapy”
Cellular Immunotherapy of Ovarian Cancer
$401,407Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Cancer Center Research Training Program
$401,365John M Maris · University Of Pennsylvania · T32 · FY2017 · CA
Optimal Pairing of Chemotherapy with Immunotherapy for Pancreatic Cancer
$401,334Peter A Cohen · Mayo Clinic Rochester · P50 · FY2018 · CA
Generating CTL Against Tumor Associated Peptide Antigens
$401,323Linda A Sherman · Scripps Research Institute, The · R01 · FY2009 · CA
Generating CTL Against Tumor Associated Peptide Antigens
$401,323Linda A Sherman · Scripps Research Institute, The · R01 · FY2008 · CA
Generating CTL Against Tumor Associated Peptide Antigens
$401,323Linda A Sherman · Scripps Research Institute, The · R01 · FY2010 · CA
Molecular Genetic Analysis of Mycobacterium tuberculosis
$401,278Albert Einstein Col Of Med Yeshiva Univ · R37 · FY2004 · AI
Mechanisms of epigenetic memory in human cells
$401,250James Karlo Nunez · University Of California Berkeley · R35 · FY2025 · GM
Utilizing Immune Phenotypes to Prevent Chronic Critical Illness
$401,250Vanessa Nomellini · University Of Cincinnati · R35 · FY2020 · GM
Role of Staphylococcus aureus alpha-hemolysin in disease
$401,218Juliane Bubeck Wardenburg · Washington University · R01 · FY2020 · AI
Blood Stem Cell Transplantation as Immunotherapy
$401,200Samuel Strober · Stanford University · P01 · FY2015 · HL
A Novel Type of Dendritic Cell in Prevention of Glomerulonephritis
$401,171Yahuan Lou · University Of Texas Hlth Sci Ctr Houston · R01 · FY2013 · DK
UCSF Autoimmunity Center of Excellence
$401,171University Of California San Francisco · U19 · FY2003 · AI
Stromal metabolism promotes therapeutic resistance in pancreatic cancer
$401,168Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
EVALUATION OF PROTEIN BASED MEDICATIONS AGAINST COCAINE
$401,165University Of Michigan At Ann Arbor · R01 · FY2001 · DA
Intra- and inter-cellular signals that drive hepato-oncogenesis
$401,163Gen-Sheng Feng · University Of California, San Diego · R01 · FY2024 · CA
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma
$401,153Yi Lin · Mayo Clinic Rochester · R01 · FY2020 · CA
Immunology of human malignant melanoma initiating cells
$401,127Markus H. Frank · Boston Children'S Hospital · R01 · FY2012 · CA
Targeting BUB 1 for radio- and immuno-sensitization of Triple Negative Breast Cancer (TNBC)
$401,117Michael Daniel Green · University Of Michigan At Ann Arbor · R21 · FY2021 · CA
Development of Novel Antibody Conjugates for Cancer Immunotherapy
$401,115Weiping Tang · University Of Wisconsin-Madison · R01 · FY2025 · CA
IL-6 and IL-6R genetic polymorphisms in immune-related adverse events caused by cancer immunotherapy
$401,115Mercedes R. Rincon · University Of Colorado Denver · R21 · FY2024 · CA
Interruption of cholesterol metabolism and replication stress response in cancer therapy
$401,115Junran Zhang · Ohio State University · R21 · FY2020 · CA
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
$401,113Binfeng Lu · Hackensack University Medical Center · R01 · FY2025 · CA
Clinical Studies for Improving Survival Rates for Oral Cancer Patients in Low Resource Settings
$401,107Manijeh N Goldberg · Privo Technologies, Llc · R44 · FY2022 · CA
GCDH Addiction in Melanoma
$401,077Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · CA